(Q36341754)

13 August 2017

1 reference

title

Expression biomarkers for clinical efficacy and outcome prediction in cancer (English)

1 reference

13 August 2017

0 references

Kathryn J Strand

1

1 reference

13 August 2017

Hanif Khalak

2

1 reference

13 August 2017

Jeffrey W Strovel

3

1 reference

13 August 2017

Reinhard Ebner

4

1 reference

13 August 2017

Meena Augustus

5

1 reference

13 August 2017

publication date

1 January 2006

1 reference

13 August 2017

1 reference

13 August 2017

volume

7

1 reference

13 August 2017

issue

1

1 reference

13 August 2017

page(s)

105-115

1 reference

The role of transcriptome analysis in pre-clinical toxicology

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

Predictors of primary breast cancers responsiveness to preoperative epirubicin/cyclophosphamide-based chemotherapy: translation of microarray data into clinically useful predictive signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

Early drug safety evaluation: biomarkers, signatures, and fingerprints

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

Gene expression microarray technologies in the development of new therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

Toxicogenomics in the pharmaceutical industry: hollow promises or real benefit?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

Molecular therapeutics: promise and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

Targeted therapies for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

Perspectives on the development of a molecularly targeted agent

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

Erlotinib in previously treated non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

Erlotinib in lung cancer - molecular and clinical predictors of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

Classification of pediatric acute lymphoblastic leukemia by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

Ribonucleotide reductase messenger RNA expression and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

A Novel Approach Toward Development of a Rapid Blood Test for Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

Significant differences in nipple aspirate fluid protein expression between healthy women and those with breast cancer demonstrated by time-of-flight mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

Proteomic analysis of nipple aspirate fluid to detect biologic markers of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

Tree analysis of mass spectral urine profiles discriminates transitional cell carcinoma of the bladder from noncancer patient

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

Proteomic patterns of tumour subsets in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

Microarrays of tumor cell derived proteins uncover a distinct pattern of prostate cancer serum immunoreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

Development of natural protein microarrays for diagnosing cancer based on an antibody response to tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

Cytochrome P450 CYP3A4/5 expression as a biomarker of outcome in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

Epithelial membrane protein-1 is a biomarker of gefitinib resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

Non-coding RNAs: new players in eukaryotic biology

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

Gene expression profiling for pharmaceutical safety assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

Predicting transcription factor activities from combined analysis of microarray and ChIP data: a partial least squares approach

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

Partial least squares dimension reduction for microarray gene expression data with a censored response

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

Support vector machine classification and validation of cancer tissue samples using microarray expression data

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

Knowledge-based analysis of microarray gene expression data by using support vector machines

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

Molecular classification of cancer types from microarray data using the combination of genetic algorithms and support vector machines

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

Prognostic classification of relapsing favorable histology Wilms tumor using cDNA microarray expression profiling and support vector machines

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

Tumor classification by tissue microarray profiling: random forest clustering applied to renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

Genomics and the search for novel biomarkers in toxicology

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

Toxicogenomics in drug discovery: from preclinical studies to clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

Chemical genetics to chemical genomics: small molecules offer big insights

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

21 January 2018

An individual approach

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.105

21 January 2018

Identifiers

DOI

10.2217/14622416.7.1.105

1 reference

13 August 2017

1 reference